Covid-19 Neurology News

New, Unpublished Data Reveals Impact of COVID-19 in Patients With Neurological Disorders

5 Oct 2021

New data for the first time reveals a connection between COVID-19 and its worsening impact on patients with existing neurological conditions. The research identifying distinct profiles of COVID-19 patients with neurological conditions and manifestations was unveiled at the XXV Biennial World Congress of Neurology (WCN) 2021 by world-renowned researcher Ettore Beghi, professor of neuroepidemiology at the University of Milan, Italy

COVID-19’s Impact on the Brain Is a Key Topic of the 25th Biennial World Congress of Neurology

3 Oct 2021

The neurological impact of COVID-19, biomarkers for traumatic brain injury and migraine pathophysiology were among the many topics discussed at the XXV Biennial World Congress of Neurology on October 3 through 7, 2021, presented by the World Federation of Neurology.

An international registry of CVT after COVID vaccination

21 Apr 2021

The International Cerebral Venous Thrombosis Consortium designed and launched an international prospective registry of cerebral venous thrombosis occurring after vaccination against COVID infection.

Mild Covid-19 May Lead to Lasting Neurologic Symptoms

30 Mar 2021

Early recognition of lasting neurologic symptoms associated with Covid-19 led specialists at Northwestern Medicine, Chicago, to open one of the nation’s first clinics devoted to treating neurological long haulers in May of 2020.

Study uncovers clues to COVID-19 using MRI, CT

12 Mar 2021

A multicenter study, published in the American Journal of Neuroradiology, finds correlation between the severity of COVID-19 in lungs, brain

Neurological Complications of COVID-19 in Children: Rare, but Patterns Emerge

10 Mar 2021

While neurological complications of COVID-19 in children are rare, in contrast to adults, an international expert review of positive neuroimaging findings in children with acute and post-infectious COVID-19 found that the most common abnormalities resembled immune-mediated patterns of disease involving the brain, spine, and nerves.

Loss of sense of smell and taste may last up to 5 months after COVID-19

17 Feb 2021

People with COVID-19 may lose their sense of smell and taste for up to five months after infection, according to a preliminary study released today, February 22, 2021, that will be presented at the American Academy of Neurology's 73rd Annual Meeting.

A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: the NeuroCOVID‐19 task Force of the EAN

18 Jan 2021

COVID‐19 continues to challenge health and care systems around the globe. The pandemic has disrupted acute neurology services and routine patient care and has impacted the clinical course in patients with chronic neurologic disease. COVID‐19 appears to have exposed inequalities of societies and healthcare systems and had disproportionate impact on already vulnerable communities. 

NIH study uncovers blood vessel damage and inflammation in COVID-19 patients’ brains but no infection

30 Dec 2020

Results from a study of 19 deceased patients suggests brain damage is a byproduct of a patient’s illness.

No association between COVID-19 and Guillain-Barré syndrome

13 Dec 2020

Neuroscientists at UCL have found no significant association between COVID-19 and the potentially paralysing and sometimes fatal neurological condition Guillain-Barré syndrome. Researchers say the findings, published in the journal Brain, along with a linked scientific commentary by UCL and other international experts, should provide the public with reassurance, as the UK’s national coronavirus vaccination programme is rolled out.
1 3